MILAE BIORESOURCES: Q1 2026 Operating Profit 440M KRW, Up 182% YoY

Q1 2026 consolidated revenue 17.04B KRW (+15.9% YoY), operating profit 0.44B KRW (+182.2%), net profit 0.54B KRW.
Feed division revenue 9.67B KRW (56.75%), Food division 7.37B KRW (43.25%); debt ratio 41.15%, net borrowing ratio 10.21%.
Sep 2025: obtained individual recognition for Tetraselmis chuii (eye health); Dec 2025: signed feed enzyme supply agreement with IFF Danisco.
Apr 2026: CEO changed to Lee Jae-hwan (largest shareholder Kim Seong-jin remains as inside director).